S
Sylvette Hoffstetter
Publications - 54
Citations - 2140
Sylvette Hoffstetter is an academic researcher. The author has contributed to research in topics: Brachytherapy & Epidermoid carcinoma. The author has an hindex of 28, co-authored 54 publications receiving 2072 citations.
Papers
More filters
Journal ArticleDOI
Impact of targeting deviations on outcome in medulloblastoma : Study of the french society of pediatric oncology (SFOP)
Christian Carrie,Sylvette Hoffstetter,Frederic Gomez,V Moncho,François Doz,Claire Alapetite,X. Murraciole,J.-P. Maire,M Benhassel,Sophie Chapet,Philippe Quetin,H. Kolodie,Jean-Léon Lagrange,J.C Cuillere,Jean-Louis Habrand +14 more
TL;DR: In this paper, a prospective study of 174 patients treated for medulloblastoma was conducted to correlate targeting deviation in external beam radiation therapy with site of relapse, and the authors found that minor deviations in therapy technique are slightly associated with an increased risk of relapse in the same range as the group with only one major deviation.
Journal ArticleDOI
Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.
Laetitia Padovani,Marie-Pierre Sunyach,David Pérol,Cédric Mercier,Claire Alapetite,Christine Haie-Meder,Sylvette Hoffstetter,Xavier Muracciole,Christine Kerr,Jean-Philippe Wagner,Jean-Léon Lagrange,J.-P. Maire,D. Cowen,Didier Frappaz,Christian Carrie +14 more
TL;DR: Results suggest that patients with standard-risk disease could be treated with radiochemotherapy, reducing doses to the craniospinal area, maintaining at least 50 Gy to the PCF, similar to those observed in children.
Journal ArticleDOI
Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications
Didier Peiffert,Pierre Bey,M. Pernot,François Guillemin,Elisabeth Luporsi,Sylvette Hoffstetter,Pierre Aletti,Patrick Boissel,Marc-André Bigard,Daniel Dartois,Francois Baylac +10 more
TL;DR: The confirmation of pretherapeutic prognostic factors related to response to the treatment should allow us to adapt the therapeutic intensity for each case to obtain better tumor control, with as few sequelae as possible, to yield a better rate of SC.
l Clinical Investigation CONSERVATIVE TREATMENT BY IRRADIATION OF EPIDERMOID CANCERS OF THE ANAL CANAL: PROGNOSTIC FACTORS OF TUMORAL CONTROL AND COMPLICATIONS
Didier Peiffert,Pierre Bey,M. Pernot,François Guillemin,Elisabeth Luporsi,Sylvette Hoffstetter,Pierre Aletti,Patrick Boissel,Marc-André Bigard,Daniel Dartois,Francois Baylac,Alexis Vautrin +11 more
Journal ArticleDOI
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol
Christian Carrie,Xavier Muracciole,Frederic Gomez,Jean-Louis Habrand,M Benhassel,Martine Mege,Marc Mahe,Philippe Quetin,Jean Philippe Maire,Françoise Soum,Marie Helene Baron,Pierre Clavere,Sophie Chapet,Zineb Gaci,H. Kolodie,Philippe Maingon,Bernard Vie,Valérie Bernier,Claire Alapetite,Sylvette Hoffstetter,Jacques Grill,Frederic Lafay +21 more
TL;DR: This hyperfractionated radiotherapy protocol with a reduced boost volume and without chemotherapy was not associated with early relapses in children, and intellectual function seemed to be preserved, which is promising.